- Letter to the Editor
- Open Access
Difficulty of the ethical decision–making process in withholding and withdrawing life-sustaining treatments in French EDs during COVID pandemic
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 28, Article number: 78 (2020)
France is one of the most impacted countries in the world by the COVID-19 pandemic, with more than 170,000 confirmed cases. Thus, one of the ethical dilemmas faced by French emergency physicians concerns the decision of withholding or withdrawing life-sustaining treatments, especially given the impact of the COVID-19. What’s more, we have already shown, prior to the outbreak of COVID-19, that the decision-making process of these decisions is especially difficult in the context of emergency medicine because of the lack of time and the absence of anticipation in chronic diseases . In the context of COVID-19, healthcare teams face several challenges with the decisions to withhold or withdraw life-sustaining treatments.
The first challenge is the fair allocation of medical resources depending on the area of France. Indeed, the Great East region, which was hit first by the pandemic, was the most impacted because of a shortage of critical care beds. The other regions were able to get organized in time and increased their ICU bed capacity. Several recommendations have since been proposed, setting the respect of ethical values and the necessity to treat people equally as a priority .
The second challenge is the communication between healthcare teams and relatives. We showed that healthcare teams expressed difficult experiences regarding the announcement and the communication with the patients and their relatives concerning these decisions . Moreover, we found that relatives suffered after a decision of withdrawing or withholding life-sustaining treatments and displayed symptoms of anxiety and depression, which persisted over time . During the COVID-19 pandemic, the relatives were not physically present in EDs because of the ban on hospital visits. Therefore, lots of announcements were made by phone and may have induced additional trauma, given that relatives were not able to accompany their loved ones.
The third challenge we identified is the impact of these decisions on the healthcare teams. We found in a previous study that the decision-making process to withhold or withdraw life-sustaining treatments often triggers a feeling of isolation and being overwhelmed among ED physicians. Mental health issues have been reported among healthcare workers, especially for those who were directly engaged in the care of patients with COVID-19 , but no data was available concerning the impact of the decisions to withhold or withdraw life-sustaining treatments. Training healthcare teams to develop an effective communication strategy in the context of a pandemic is a fundamental step in preventing stress disorders, and must be evaluated for improvement.
Douplat M, Berthiller J, Schott AM, Potinet V, Le Coz P, Tazarourte K, et al. Difficulty of the decision-making process in emergency departments for end-of-life patients. J Eval Clin Pract. 2019;25:1–7.
Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;382(21):2049–55.
Douplat M, Fraticelli L, Claustre C, Peiretti A, Serre P, Bischoff M, Jacquin L, Freyssenge J, Schott AM, Tazarourte K, Frugier S, Khoury CEL, LAT group. Management of decision of withholding and withdrawing life-sustaining treatments in French EDs. Scand J Trauma Resusc Emerg Med. 2020;28(1):52.
Douplat M, Masbou H, Tazarourte K, Berthiller J, Potinet V, Le Coz P, Schott AM, Jacquin L. Symptoms of anxiety and depression in relatives after decisions of withholding and withdrawing life-sustaining treatments in emergency departments. Eur J Emerg Med. 2020. https://doi.org/10.1097/MEJ.0000000000000669.
Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976.
We thank Ashley Doerwald and Benjamin Douplat for the English proofreading of the manuscript.
There is no financial support for the investigation or manuscript development.
The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Douplat, M., Jacquin, L., Frugier, S. et al. Difficulty of the ethical decision–making process in withholding and withdrawing life-sustaining treatments in French EDs during COVID pandemic. Scand J Trauma Resusc Emerg Med 28, 78 (2020). https://doi.org/10.1186/s13049-020-00772-3